These publications were authored or co-authored by Quest Diagnostics staff.
The dangers of including nonclassical cystic fibrosis variants in population-based screening panels: p.L997F, further genotype/phenotype correlation data.Quest Diagnostics Authors: Strom, C
Authors: Redman JB, Peng M.
Genet Med. 2011;13:1042-1044.
Authors: Crossley B, Buller-Buerkle A, Jarvis M, Quan F, Peng M, Muralidharan K, Pratt V, Redman JB, Sun W.
Genet Med. 2011;13:166-172.
Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory.Quest Diagnostics Authors: Strom, C
Authors: Goos D, Crossley B, Zhang K, Buller-Burkle A, Jarvis M, Quan F, Peng M, Sun W.
Genet Med. 2012;14:95-100.
Genetic testing for early detection of individuals at risk of coronary heart disease and monitoring response to therapy: challenges and promises.Authors: Superko HR, Roberts R, Agatston A, Frohwein S, Reingold JS, White TJ, Sninsky JJ, Margolis B, Momary KM, Garrett BC, King SB, III.
Curr Atheroscler Rep. 2011;13:396-404.
Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.Authors: Wang X, Qian X, Beitler JJ, Chen ZG, Khuri FR, Lewis MM, Shin HJ, Nie S, Shin DM.
Cancer Res. 2011;71:1526-1532.